Reports

Industry Research Reports

Home > Reports > Medical Care > Global In-Vitro Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global In-Vitro Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global In-Vitro Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Medical Care

Published Date: 2025-03-19

Pages: 106 Pages

Report ld: 4682201

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

In-Vitro Diagnostics Market Size(US$)

den_QYR1
cagr

CAGR 2025-2031

4.4%

marketSize

Market Size,2031

USD 94,510

Million

Market Snapshot

Market Size in 2025 (Value)
US$ 72,990 million
Market Forecast in 2031(Value)
US$ 94,510 million
CAGR
4.4%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global In-Vitro Diagnostics market size was US$ 70210 million in 2024 and is forecast to a readjusted size of US$ 94510 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.

In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report， we counted In-Vitro Diagnostics reagent.

The concentration of the market is relatively high, and the first 16 companies include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD, JNJ, Sysmex, KHB, DaAn Gene, Leadman, BioSino, BSBE and Maccura, they occupied more than 66% of whole market. US dominates the market which occupied 43% of the whole market. Europe, continuing healthcare reforms, will increase the demand. China is going to be a major player in the future, who occupied 7% of the whole market.

The global In-Vitro Diagnostics market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.

MARKET SEGMENTATION

By Company

  • Roche
  • Siemens
  • Abbott
  • Danaher
  • Thermo Fisher
  • BioMerieux
  • Bio-Rad
  • BD
  • JNJ
  • Sysmex
  • KHB
  • DaAn Gene
  • Leadman
  • BioSino
  • BSBE
  • Maccura

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Tissue Diagnostics
  • Professional Diagnostic
  • Molecular Diagnostic
  • Diabetes Monitoring
  • Other

Segment by Application

  • Diabetes
  • Infectious Diseases
  • Oncology
  • Cardiology
  • HIV
  • Other

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).

marn_i1

Chapter 2: Quantitative analysis of In-Vitro Diagnostics market size and growth potential at global, regional, and country levels.

marn_i1

Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).

marn_i1

Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Professional Diagnostic in China).

marn_i1

Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Infectious Diseases in India).

marn_i1

Chapter 6: Regional revenue breakdown by company, type, application and customer.

marn_i1

Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.

marn_i1

Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.

marn_i1

Chapter 9: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the In-Vitro Diagnostics value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031

1.2.2 Tissue Diagnostics

1.2.3 Professional Diagnostic

1.2.4 Molecular Diagnostic

1.2.5 Diabetes Monitoring

1.2.6 Other

1.3 Market by Application

1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031

1.3.2 Diabetes

1.3.3 Infectious Diseases

1.3.4 Oncology

1.3.5 Cardiology

1.3.6 HIV

1.3.7 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Global Growth Trends

2.1 Global In-Vitro Diagnostics Market Perspective (2020-2031)

2.2 Global Market Size by Region: 2020 VS 2024 VS 2031

2.3 Global In-Vitro Diagnostics Revenue Market Share by Region (2020-2025)

2.4 Global In-Vitro Diagnostics Revenue Forecast by Region (2026-2031)

2.5 Major Region and Emerging Market Analysis

2.5.1 North America In-Vitro Diagnostics Market Size and Prospective (2020-2031)

2.5.2 Europe In-Vitro Diagnostics Market Size and Prospective (2020-2031)

2.5.3 China In-Vitro Diagnostics Market Size and Prospective (2020-2031)

2.5.4 Japan In-Vitro Diagnostics Market Size and Prospective (2020-2031)

muLu

3 Breakdown Data by Type

3.1 Global In-Vitro Diagnostics Historic Market Size by Type (2020-2025)

3.2 Global In-Vitro Diagnostics Forecasted Market Size by Type (2026-2031)

3.3 Different Types In-Vitro Diagnostics Representative Players

muLu

4 Breakdown Data by Application

4.1 Global In-Vitro Diagnostics Historic Market Size by Application (2020-2025)

4.2 Global In-Vitro Diagnostics Forecasted Market Size by Application (2026-2031)

4.3 New Sources of Growth in In-Vitro Diagnostics Application

muLu

5 Competition Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top In-Vitro Diagnostics Players by Revenue (2020-2025)

5.1.2 Global In-Vitro Diagnostics Revenue Market Share by Players (2020-2025)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by In-Vitro Diagnostics Revenue

5.4 Global In-Vitro Diagnostics Market Concentration Analysis

5.4.1 Global In-Vitro Diagnostics Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by In-Vitro Diagnostics Revenue in 2024

5.5 Global Key Players of In-Vitro Diagnostics Head office and Area Served

5.6 Global Key Players of In-Vitro Diagnostics, Product and Application

5.7 Global Key Players of In-Vitro Diagnostics, Date of Enter into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

muLu

6 Region Analysis

6.1 North America Market: Players, Segments and Downstream

6.1.1 North America In-Vitro Diagnostics Revenue by Company (2020-2025)

6.1.2 North America Market Size by Type

6.1.2.1 North America In-Vitro Diagnostics Market Size by Type (2020-2025)

6.1.2.2 North America In-Vitro Diagnostics Market Share by Type (2020-2025)

6.1.3 North America Market Size by Application

6.1.3.1 North America In-Vitro Diagnostics Market Size by Application (2020-2025)

6.1.3.2 North America In-Vitro Diagnostics Market Share by Application (2020-2025)

6.1.4 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments and Downstream

6.2.1 Europe In-Vitro Diagnostics Revenue by Company (2020-2025)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe In-Vitro Diagnostics Market Size by Type (2020-2025)

6.2.2.2 Europe In-Vitro Diagnostics Market Share by Type (2020-2025)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe In-Vitro Diagnostics Market Size by Application (2020-2025)

6.2.3.2 Europe In-Vitro Diagnostics Market Share by Application (2020-2025)

6.2.4 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments and Downstream

6.3.1 China In-Vitro Diagnostics Revenue by Company (2020-2025)

6.3.2 China Market Size by Type

6.3.2.1 China In-Vitro Diagnostics Market Size by Type (2020-2025)

6.3.2.2 China In-Vitro Diagnostics Market Share by Type (2020-2025)

6.3.3 China Market Size by Application

6.3.3.1 China In-Vitro Diagnostics Market Size by Application (2020-2025)

6.3.3.2 China In-Vitro Diagnostics Market Share by Application (2020-2025)

6.3.4 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments and Downstream

6.4.1 Japan In-Vitro Diagnostics Revenue by Company (2020-2025)

6.4.2 Japan Market Size by Type

6.4.2.1 Japan In-Vitro Diagnostics Market Size by Type (2020-2025)

6.4.2.2 Japan In-Vitro Diagnostics Market Share by Type (2020-2025)

6.4.3 Japan Market Size by Application

6.4.3.1 Japan In-Vitro Diagnostics Market Size by Application (2020-2025)

6.4.3.2 Japan In-Vitro Diagnostics Market Share by Application (2020-2025)

6.4.4 Japan Market Trend and Opportunities

muLu

7 Key Players Profiles

7.1 Roche

7.1.1 Roche Company Details

7.1.2 Roche Business Overview

7.1.3 Roche In-Vitro Diagnostics Introduction

7.1.4 Roche Revenue in In-Vitro Diagnostics Business (2020-2025)

7.1.5 Roche Recent Development

7.2 Siemens

7.2.1 Siemens Company Details

7.2.2 Siemens Business Overview

7.2.3 Siemens In-Vitro Diagnostics Introduction

7.2.4 Siemens Revenue in In-Vitro Diagnostics Business (2020-2025)

7.2.5 Siemens Recent Development

7.3 Abbott

7.3.1 Abbott Company Details

7.3.2 Abbott Business Overview

7.3.3 Abbott In-Vitro Diagnostics Introduction

7.3.4 Abbott Revenue in In-Vitro Diagnostics Business (2020-2025)

7.3.5 Abbott Recent Development

7.4 Danaher

7.4.1 Danaher Company Details

7.4.2 Danaher Business Overview

7.4.3 Danaher In-Vitro Diagnostics Introduction

7.4.4 Danaher Revenue in In-Vitro Diagnostics Business (2020-2025)

7.4.5 Danaher Recent Development

7.5 Thermo Fisher

7.5.1 Thermo Fisher Company Details

7.5.2 Thermo Fisher Business Overview

7.5.3 Thermo Fisher In-Vitro Diagnostics Introduction

7.5.4 Thermo Fisher Revenue in In-Vitro Diagnostics Business (2020-2025)

7.5.5 Thermo Fisher Recent Development

7.6 BioMerieux

7.6.1 BioMerieux Company Details

7.6.2 BioMerieux Business Overview

7.6.3 BioMerieux In-Vitro Diagnostics Introduction

7.6.4 BioMerieux Revenue in In-Vitro Diagnostics Business (2020-2025)

7.6.5 BioMerieux Recent Development

7.7 Bio-Rad

7.7.1 Bio-Rad Company Details

7.7.2 Bio-Rad Business Overview

7.7.3 Bio-Rad In-Vitro Diagnostics Introduction

7.7.4 Bio-Rad Revenue in In-Vitro Diagnostics Business (2020-2025)

7.7.5 Bio-Rad Recent Development

7.8 BD

7.8.1 BD Company Details

7.8.2 BD Business Overview

7.8.3 BD In-Vitro Diagnostics Introduction

7.8.4 BD Revenue in In-Vitro Diagnostics Business (2020-2025)

7.8.5 BD Recent Development

7.9 JNJ

7.9.1 JNJ Company Details

7.9.2 JNJ Business Overview

7.9.3 JNJ In-Vitro Diagnostics Introduction

7.9.4 JNJ Revenue in In-Vitro Diagnostics Business (2020-2025)

7.9.5 JNJ Recent Development

7.10 Sysmex

7.10.1 Sysmex Company Details

7.10.2 Sysmex Business Overview

7.10.3 Sysmex In-Vitro Diagnostics Introduction

7.10.4 Sysmex Revenue in In-Vitro Diagnostics Business (2020-2025)

7.10.5 Sysmex Recent Development

7.11 KHB

7.11.1 KHB Company Details

7.11.2 KHB Business Overview

7.11.3 KHB In-Vitro Diagnostics Introduction

7.11.4 KHB Revenue in In-Vitro Diagnostics Business (2020-2025)

7.11.5 KHB Recent Development

7.12 DaAn Gene

7.12.1 DaAn Gene Company Details

7.12.2 DaAn Gene Business Overview

7.12.3 DaAn Gene In-Vitro Diagnostics Introduction

7.12.4 DaAn Gene Revenue in In-Vitro Diagnostics Business (2020-2025)

7.12.5 DaAn Gene Recent Development

7.13 Leadman

7.13.1 Leadman Company Details

7.13.2 Leadman Business Overview

7.13.3 Leadman In-Vitro Diagnostics Introduction

7.13.4 Leadman Revenue in In-Vitro Diagnostics Business (2020-2025)

7.13.5 Leadman Recent Development

7.14 BioSino

7.14.1 BioSino Company Details

7.14.2 BioSino Business Overview

7.14.3 BioSino In-Vitro Diagnostics Introduction

7.14.4 BioSino Revenue in In-Vitro Diagnostics Business (2020-2025)

7.14.5 BioSino Recent Development

7.15 BSBE

7.15.1 BSBE Company Details

7.15.2 BSBE Business Overview

7.15.3 BSBE In-Vitro Diagnostics Introduction

7.15.4 BSBE Revenue in In-Vitro Diagnostics Business (2020-2025)

7.15.5 BSBE Recent Development

7.16 Maccura

7.16.1 Maccura Company Details

7.16.2 Maccura Business Overview

7.16.3 Maccura In-Vitro Diagnostics Introduction

7.16.4 Maccura Revenue in In-Vitro Diagnostics Business (2020-2025)

7.16.5 Maccura Recent Development

muLu

8 In-Vitro Diagnostics Market Dynamics

8.1 In-Vitro Diagnostics Industry Trends

8.2 In-Vitro Diagnostics Market Drivers

8.3 In-Vitro Diagnostics Market Challenges

8.4 In-Vitro Diagnostics Market Restraints

muLu

9 Research Findings and Conclusion

muLu

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global In-Vitro Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global In-Vitro Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market In-Vitro Diagnostics Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global In-Vitro Diagnostics Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global In-Vitro Diagnostics Revenue Share by Region (2020-2025)
Table 6. Global In-Vitro Diagnostics Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global In-Vitro Diagnostics Revenue Share Forecast by Region (2026-2031)
Table 8. Global In-Vitro Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global In-Vitro Diagnostics Revenue Market Share by Type (2020-2025)
Table 10. Global In-Vitro Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global In-Vitro Diagnostics Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global In-Vitro Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global In-Vitro Diagnostics Revenue Market Share by Application (2020-2025)
Table 15. Global In-Vitro Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global In-Vitro Diagnostics Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in In-Vitro Diagnostics Application
Table 18. Global In-Vitro Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global In-Vitro Diagnostics Market Share by Players (2020-2025)
Table 20. Global Top In-Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Diagnostics as of 2024)
Table 21. Ranking of Global Top In-Vitro Diagnostics Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by In-Vitro Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of In-Vitro Diagnostics, Headquarters and Area Served
Table 24. Global Key Players of In-Vitro Diagnostics, Product and Application
Table 25. Global Key Players of In-Vitro Diagnostics, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America In-Vitro Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America In-Vitro Diagnostics Revenue Market Share by Company (2020-2025)
Table 29. North America In-Vitro Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America In-Vitro Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe In-Vitro Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe In-Vitro Diagnostics Revenue Market Share by Company (2020-2025)
Table 33. Europe In-Vitro Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe In-Vitro Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 35. China In-Vitro Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 36. China In-Vitro Diagnostics Revenue Market Share by Company (2020-2025)
Table 37. China In-Vitro Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 38. China In-Vitro Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan In-Vitro Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan In-Vitro Diagnostics Revenue Market Share by Company (2020-2025)
Table 41. Japan In-Vitro Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan In-Vitro Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 43. Roche Company Details
Table 44. Roche Business Overview
Table 45. Roche In-Vitro Diagnostics Product
Table 46. Roche Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 47. Roche Recent Development
Table 48. Siemens Company Details
Table 49. Siemens Business Overview
Table 50. Siemens In-Vitro Diagnostics Product
Table 51. Siemens Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 52. Siemens Recent Development
Table 53. Abbott Company Details
Table 54. Abbott Business Overview
Table 55. Abbott In-Vitro Diagnostics Product
Table 56. Abbott Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 57. Abbott Recent Development
Table 58. Danaher Company Details
Table 59. Danaher Business Overview
Table 60. Danaher In-Vitro Diagnostics Product
Table 61. Danaher Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 62. Danaher Recent Development
Table 63. Thermo Fisher Company Details
Table 64. Thermo Fisher Business Overview
Table 65. Thermo Fisher In-Vitro Diagnostics Product
Table 66. Thermo Fisher Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 67. Thermo Fisher Recent Development
Table 68. BioMerieux Company Details
Table 69. BioMerieux Business Overview
Table 70. BioMerieux In-Vitro Diagnostics Product
Table 71. BioMerieux Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 72. BioMerieux Recent Development
Table 73. Bio-Rad Company Details
Table 74. Bio-Rad Business Overview
Table 75. Bio-Rad In-Vitro Diagnostics Product
Table 76. Bio-Rad Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 77. Bio-Rad Recent Development
Table 78. BD Company Details
Table 79. BD Business Overview
Table 80. BD In-Vitro Diagnostics Product
Table 81. BD Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 82. BD Recent Development
Table 83. JNJ Company Details
Table 84. JNJ Business Overview
Table 85. JNJ In-Vitro Diagnostics Product
Table 86. JNJ Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 87. JNJ Recent Development
Table 88. Sysmex Company Details
Table 89. Sysmex Business Overview
Table 90. Sysmex In-Vitro Diagnostics Product
Table 91. Sysmex Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 92. Sysmex Recent Development
Table 93. KHB Company Details
Table 94. KHB Business Overview
Table 95. KHB In-Vitro Diagnostics Product
Table 96. KHB Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 97. KHB Recent Development
Table 98. DaAn Gene Company Details
Table 99. DaAn Gene Business Overview
Table 100. DaAn Gene In-Vitro Diagnostics Product
Table 101. DaAn Gene Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 102. DaAn Gene Recent Development
Table 103. Leadman Company Details
Table 104. Leadman Business Overview
Table 105. Leadman In-Vitro Diagnostics Product
Table 106. Leadman Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 107. Leadman Recent Development
Table 108. BioSino Company Details
Table 109. BioSino Business Overview
Table 110. BioSino In-Vitro Diagnostics Product
Table 111. BioSino Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 112. BioSino Recent Development
Table 113. BSBE Company Details
Table 114. BSBE Business Overview
Table 115. BSBE In-Vitro Diagnostics Product
Table 116. BSBE Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 117. BSBE Recent Development
Table 118. Maccura Company Details
Table 119. Maccura Business Overview
Table 120. Maccura In-Vitro Diagnostics Product
Table 121. Maccura Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 122. Maccura Recent Development
Table 123. In-Vitro Diagnostics Market Trends
Table 124. In-Vitro Diagnostics Market Drivers
Table 125. In-Vitro Diagnostics Market Challenges
Table 126. In-Vitro Diagnostics Market Restraints
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. In-Vitro Diagnostics Product Picture
Figure 2. Global In-Vitro Diagnostics Market Share by Type: 2024 VS 2031
Figure 3. Tissue Diagnostics Features
Figure 4. Professional Diagnostic Features
Figure 5. Molecular Diagnostic Features
Figure 6. Diabetes Monitoring Features
Figure 7. Other Features
Figure 8. Global In-Vitro Diagnostics Market Share by Application: 2024 VS 2031
Figure 9. Diabetes
Figure 10. Infectious Diseases
Figure 11. Oncology
Figure 12. Cardiology
Figure 13. HIV
Figure 14. Other
Figure 15. In-Vitro Diagnostics Report Years Considered
Figure 16. Global In-Vitro Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global In-Vitro Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global In-Vitro Diagnostics Revenue Market Share by Region: 2020 VS 2024
Figure 19. North America In-Vitro Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Europe In-Vitro Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. China In-Vitro Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Japan In-Vitro Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. Global In-Vitro Diagnostics Market Share by Players in 2024
Figure 24. Global Top In-Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Diagnostics as of 2024)
Figure 25. The Top 10 and 5 Players Market Share by In-Vitro Diagnostics Revenue in 2024
Figure 26. North America In-Vitro Diagnostics Market Share by Type (2020-2025)
Figure 27. North America In-Vitro Diagnostics Market Share by Application (2020-2025)
Figure 28. Europe In-Vitro Diagnostics Market Share by Type (2020-2025)
Figure 29. Europe In-Vitro Diagnostics Market Share by Application (2020-2025)
Figure 30. China In-Vitro Diagnostics Market Share by Type (2020-2025)
Figure 31. China In-Vitro Diagnostics Market Share by Application (2020-2025)
Figure 32. Japan In-Vitro Diagnostics Market Share by Type (2020-2025)
Figure 33. Japan In-Vitro Diagnostics Market Share by Application (2020-2025)
Figure 34. Roche Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 35. Siemens Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 36. Abbott Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 37. Danaher Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 38. Thermo Fisher Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 39. BioMerieux Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 40. Bio-Rad Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 41. BD Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 42. JNJ Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 43. Sysmex Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 44. KHB Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 45. DaAn Gene Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 46. Leadman Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 47. BioSino Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 48. BSBE Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 49. Maccura Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of In-Vitro Diagnostics in 2025?zhanKai
The global market size of In-Vitro Diagnostics in 2025 was 72990 Million USD.
Which companies rank high in the global In-Vitro Diagnostics market?shouQi
What was the global market size of In-Vitro Diagnostics in 2031?shouQi
Which region is expected to have the highest market share?shouQi
What is the annual compound growth rate of the global In-Vitro Diagnostics market size from 2025 to 2031?shouQi
den_biaoTiZhungShi

Related Reports

Global In-Vitro Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Medical Care

Published Date: 2025-03-19

Pages: 106 Pages

Report ld: 4682201

CHOOSE LICENSE TYPE
tip

USD 4250.00

tip

USD 6375.00

tip

USD 8500.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

SIMON LEE

+1-62 6295 2442

English,Chinese

Offline

HITESH

HITESH

+91-86 6998 6909

English, Hindi

Online

TANG XIN

TANG XIN

+81-90 3800 9273

Japanese,English

Online

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Online

YUJIE TIAN

YUJIE TIAN

+86-135-2215-3954

Chinese, English

Online

DAMON

DAMON

+86-133 1872 9947

Chinese, English

Online

General Email:
global@qyresearch.com

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

WHY THIS REPORT

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now